Fosun Pharma has the exclusive rights to market and sell tenapanor in China, Hong Kong and Macau. Tenapanor will be marketed with the Chinese trade name Wan Ti Le.
By Julie Zhu HONG KONG (Reuters) -State-owned China International Capital Corp (CICC) is set to merge with its peer China ...
Foreign investors could become more confident about equity markets in Hong Kong and mainland China if enhancements were made ...
--China International Capital Corp. and peer China Galaxy Securities plan to merge, Reuters reported, citing unnamed sources. --The merger, which would create China's third-largest brokerage, has ...
AIX Inc. (NASDAQ: AIFU) (“AIX” or the “Company”), today announced that it has received a written notification from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC ...
The U.S. Securities and Exchange Commission has ended its investigation into Robinhood Crypto saying it will not pursue ...
ARK Invest's Cathie Wood says the odds of Bitcoin hitting $1.5M "have gone up," CZ's dog’s name sparked a memecoin frenzy, ...
China has seen a significant rise in the prosecution of securities-related crimes in the past three years, demonstrating its strengthened efforts to ensure the high-quality development of the capital ...
BEIJING -- Chinese procurators prosecuted 1,011 people for securities-related crimes from 2022 to 2024, an annual rise of 16 percent on average, the Supreme People's Procuratorate (SPP) said on Friday ...
Hong Kong’s SFC has introduced its ASPIRe roadmap to establish the city as a crypto hub, addressing regulatory gaps and ...
BEIJING: China's purchases of chipmaking equipment are set to decline this year after three years of growth, as the industry grapples with overcapacity and faces greater constraints from US ...
But this time they have set specific targets. China Securities Regulatory Commission (CSRC) head Wu Qing has said big state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results